Daniel Judge, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alexion
    Topic:
    Cardiac Amyloid
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alnylam
    Topic:
    Cardiac Amyloid
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bayer
    Topic:
    Cardiac Amyloid
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    BridgeBio
    Topic:
    Cardiac Amyloid
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Lexeo Therapeutics
    Topic:
    Cardiac Genetics
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novo Nordisk
    Topic:
    Cardiac Amyloid
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Rocket Pharmaceuticals
    Topic:
    Cardiac Genetics
    Date added:
    08/24/2026
    Date updated:
    08/24/2026
Return to SC & NC Chapters ACC 33rd Annual Joint Conference